Generic Drug Price-Fixing Settlement: Who Qualifies and How to File

A group of State Attorneys General sued several generic drug manufacturers, claiming they illegally conspired to fix prices and divide up customers for a wide range of generic prescription drugs sold across the United States. The lawsuit alleges this scheme caused consumers to overpay for these medications. The companies deny any wrongdoing. Apotex, Bausch, Lannett, Glenmark, and Heritage have agreed to settle the claims against them without admitting fault. The case concerns pricing practices only, it does not raise any questions about the safety or effectiveness of the drugs themselves.

So far, the States have secured roughly $25 to $30 million for consumers, with additional settlements expected down the line. Litigation continues against several other manufacturers, including Teva, Sandoz, Mylan, Pfizer, and Aurobindo. A plan has been proposed for distributing the settlement funds to eligible consumers, but no payments will go out until the Court gives final approval at a hearing scheduled for September 8, 2027.

You may be eligible if you personally purchased one or more drugs from the official Drug List somewhere in the United States between May 1, 2009 and December 31, 2019, as long as you weren't buying for resale or purchasing directly from one of the defendant companies, and you're not an officer, director, manager, or employee of a defendant. To participate, you'll need to submit a signed, completed claim form by March 8, 2027. Filing by that deadline also means you'll automatically be considered for any future settlement payments, with no need to file again.

Most claimants will choose between two filing options. Option 1 is the straightforward route: you simply certify that you made qualifying purchases and receive an equal share alongside everyone else who selects this option. Option 2 suits those with significant out-of-pocket spending: you estimate your total purchases of listed drugs during the covered period, and your payment is calculated based on that estimate. Importantly, Option 2 payouts will never fall below what Option 1 provides. If you don't select an option, you'll default to Option 1. Residents of Alabama, Arkansas, Hawaii, and Texas skip this choice entirely and instead receive a fixed payment from the Apotex settlement. The exact payment amounts aren't yet known, since they'll depend on the total number of valid claims filed and the funds available for distribution.

Filing doesn't require any receipts or proof of purchase upfront. The claim form asks for your name, date of birth, mailing address, email, and phone number, along with your preferred payment method, PayPal, Venmo, Zelle, or a mailed check. Electronic payment is recommended since mailed checks could take considerably longer to arrive. You'll need to sign and date a statement affirming your eligibility. For those choosing Option 2, the claims administrator may later request documentation supporting your purchase estimate, and missing records could impact your payout. If any part of your claim is incomplete or raises a question, you'll be notified and given 21 days to correct it.